Koers MERCK Kommanditgesellschaft auf Aktien Other OTC
Aandelen
MKKGY
US5893392093
Farmaceutische producten
Omzet 2024 * | 21,32 mld. 22,84 mld. | Omzet 2025 * | 22,64 mld. 24,25 mld. | Marktkapitalisatie | 67,28 mld. 72,07 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 2,99 mld. 3,21 mld. | Nettowinst (verlies) 2025 * | 3,52 mld. 3,77 mld. | EV/omzet 2024 * | 3,45 x |
Nettoschuld 2024 * | 6,38 mld. 6,84 mld. | Nettoschuld 2025 * | 4,56 mld. 4,89 mld. | EV/omzet 2025 * | 3,17 x |
K/w-verhouding 2024 * |
22,5
x | K/w-verhouding 2025 * |
19
x | Werknemers | - |
Dividendrendement 2024 * |
1,5% | Dividendrendement 2025 * |
1,65% | Vrij verhandelbaar | 29,71% |
Recentste transcriptie over MERCK Kommanditgesellschaft auf Aktien
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 13-07-20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01-08-14 |
Director of Finance/CFO | 54 | 26-04-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 75 | 09-05-14 | |
Christian Raabe
BRD | Director/Board Member | - | - |
Chairman | 67 | 26-04-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,93% | 9,05 mld. | |
+17,59% | 4,39 mld. | |
-22,81% | 4,4 mld. | |
+25,93% | 3,94 mld. | |
+4,64% | 2,1 mld. | |
+9,09% | 1,97 mld. | |
-36,86% | 1,87 mld. | |
-0,50% | 1,64 mld. | |
-48,24% | 1,61 mld. |